Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03458520

Pediatric PET/MR Image Registry

The purpose of this study is to compare whole body magnetic resonance (MR) imaging, whole body positron emission tomography (PET)/MR imaging, and (if available) PET/Computed Tomography (CT) imaging for the diagnosis of tumors in children and young adults. Sensitivities, specificities and diagnostic accuracies of the different imaging modalities will be compared for significant differences.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Soft Tissue Hemic and Lymphatic Diseases Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoma Lymphoproliferative Disorders Neoplasms Neoplasms by Histologic Type Neoplasms, Bone Tissue Neoplasms, Connective Tissue Neoplasms, Connective and Soft Tissue Osteosarcoma Sarcoma

Age range

Up to 40 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Stanford University, School of Medicine

Palo Alto, California, 94304, United States

Location status: Recruiting

Location contact

Anne Muehe

CONTACT

[email protected]

650-720-8601

Heike Daldrup-Link, MD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with proven solid tumors or newly diagnosed mass strongly suspected to represent a solid tumor.
  • We might also include some patients with leukemia if there is concern for a focal lesion in any of their organs.
  • Participant's parents (if participant is under 18) or the participant (if participant is 18 years or older) must willingly give written informed consent prior to any image transfer to the image registry.

Exclusion criteria

  • Patient has contraindications for MRI or PET/MR. This includes patients with cardiac pacemakers or intracranial vascular clips as well as patients with a blood glucose level > 200 mg/dl.
  • Lack of parental permission (if participant is younger than 18) or lack of informed consent (if participant is at least 18 years of age).
  • Patient has a CNS primary tumor.
  • Pregnant women and fetuses

Treatment and study plan

PET/MR Imaging

Diagnostic Test

undergo PET/MR imaging

Other names: positron emission tomography

MR imaging

Diagnostic Test

Undergo MR imaging

Other names: magnetic resonance imaging

PET/CT imaging

Diagnostic Test

Undergo PET/CT imaging

Other names: computed tomography

Primary outcomes

  1. Number of tumors

    Time frame: up to 12 months

    Number of tumors detected on whole body MRI, PET/MR and (if available) PET/CT scans.

Secondary outcomes

  1. Metabolic activity of tumors

    Time frame: up to 12 months

    Metabolic activity of tumors determined by Standardized Uptake Values (SUV) on PET/MR and (if available) PET/CT scans.

Study contacts

Contact information is provided by the study sponsor or research team.

Anne Muehe

CONTACT

[email protected]

650-720-8601

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Important dates

Study start
2018
Primary completion
2026
Study completion
2026
First posted
Mar 8, 2018
Registry last updated
Feb 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.